Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Open in API
Filings indexed 2,618 across all filing types
Latest filing 2019-03-25 Investor Presentation
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 60% confidence The document is very short (470 characters) and consists solely of a schedule listing analyst and institutional investor meetings with dates, venues, and types of meetings. There is no financial data, no report content, no regulatory or legal information, and no announcement of voting results or management changes. It is essentially a meeting schedule, which aligns most closely with an Investor Presentation (IP) or a related investor communication. However, since it is just a schedule of meetings rather than a detailed presentation or report, it does not fit the detailed investor presentation category fully. Given the options, the best fit is Investor Presentation (IP) as it relates to investor communications and meetings. Confidence is moderate due to the minimal content but clear investor focus.
2019-03-25 English
Please find attached letter regarding schedule of analyst/institutional investor meetings of the Company.
Investor Presentation Classification · 60% confidence The document contains a schedule of analyst and institutional investor meetings with the company, listing dates, investor names, venues, and types of meetings. There is no financial data, report content, or regulatory filing information. The document is very short (478 characters) and appears to be an announcement or schedule related to investor relations activities rather than a formal report or filing. It does not fit into categories like Annual Report, Earnings Release, or Call Transcript. The best fit is Investor Presentation (IP) since it relates to investor meetings and presentations, although it is more of a schedule than a full presentation. Given the limited content, confidence is moderate.
2019-03-25 English
Allotment of ESOP/ESPS
Regulatory Filings Classification · 95% confidence The document text is extremely short (59 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any detailed information. Given the lack of content, this cannot be classified as a full report or detailed filing. It is most consistent with a Regulatory Filing (RNS) as a fallback category for miscellaneous or insufficient content documents.
2019-03-20 English
Allotment of 2,218 equity shares under Employee Stock Option Scheme 2013 - A of the Company.
Regulatory Filings Classification · 100% confidence The document text is extremely short (59 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of content, this cannot be classified as a report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings with no specific information.
2019-03-20 English
Please find attached letter regarding schedule of analyst / institutional investor meetings of the Company.
AGM Information Classification · 70% confidence The document is extremely short (122 characters) and contains a simple table listing a date, fund/investor name, venue, and type of meeting. There is no detailed content, financial data, or report information. It appears to be a brief summary or schedule related to a meeting, likely an Annual General Meeting (AGM) or similar. Given the brevity and nature, it fits best as AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related meeting information. Confidence is moderate due to minimal content but clear meeting context.
2019-03-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is extremely short (122 characters) and contains only a simple table listing a date, fund/investor name, venue, and type of meeting. There is no detailed content, financial data, or report information. It appears to be a brief meeting attendance or schedule note rather than a formal report or announcement. Given the brevity and nature, it does not fit into any detailed report category. It is best classified as a Regulatory Filing (RNS) as a fallback for miscellaneous filings that do not fit other categories.
2019-03-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.